Hjem › Medulloblastom › Californien
Medulloblastom kliniske forsøg i Californien
6 studier for Medulloblastom søger deltagere på steder i Californien.
Byer i Californien
Officiel studietekst (engelsk)
Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease
- University of California, San Francisco, San Francisco
RekruttererFase 1/2
Alder 1 til 25 · Alle køn · Opdateret 28. sep. 2026 · NCT07346157Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- Lucille Packard Children's Hospital Stanford, Palo Alto
RekruttererFase 2
59 Months · Alle køn · Opdateret 15. sep. 2026 · NCT05535166GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
- Lucile Packard Children's Hospital Stanford, Palo Alto
RekruttererFase 1
Alder 1 til 30 · Alle køn · Opdateret 11. sep. 2026 · NCT07087002A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- Loma Linda University Medical Center, Loma Linda
- Miller Children's and Women's Hospital Long Beach, Long Beach
- Children's Hospital Los Angeles, Los Angeles
- og 6 flere
RekruttererFase 3
Alder 4 til 21 · Alle køn · Opdateret 25. aug. 2026 · NCT05382338DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- UCSF Benioff Children's Hospital Oakland, Oakland
- UC Davis Comprehensive Cancer Center, Sacramento
- Rady Children's Hospital, San Diego
- og 1 flere
RekruttererFase 2
Op til 21 år · Alle køn · Opdateret 12. aug. 2026 · NCT04696029Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
- Children's Hospital of Los Angeles, Los Angeles
- Rady Children's Hospital, San Diego
- University of California, San Francisco, San Francisco
Rekrutterer
12 Months – 39 Years · Alle køn · Opdateret 11. aug. 2026 · NCT05057702Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.